Fundraising Fox

Yaron Daniely

Investor

General Partner at aMoon

Israel

About

Yaron Daniely is a General Partner at aMoon, where he co-leads Velocity, an early-stage fund focused on cutting-edge technologies aimed at accelerating cures. Before aMoon, he was President and CEO of Yissum, Hebrew University's technology transfer company, and Co-Chairperson of the Israel Technology Transfer Network, following 14 years as a senior executive (10 as CEO) at private and NASDAQ-traded biopharma and biotech companies. He holds a PhD from the Sackler Institute of Graduate Biomedical Sciences at NYU School of Medicine and an MBA from the Technion.

Invests in

BiotechDigital HealthHealthtech

Experience

  1. LyfegenBoard Observercurrent2022 β€” presentBasel, Switzerland
  2. Coltac Therapeutics Ltd.Investor & Chairpersoncurrent2022 β€” presentIsrael
  3. caVos BiotherapeuticsInvestor & Chairpersoncurrent2021 β€” presentIsrael
  4. Nectin TherapeuticsInvestor & Chairpersoncurrent2020 β€” presentIsrael
  5. aMoon FundGeneral Partnercurrent2019 β€” presentRaanana, Israel
  6. MetaSight DiagnosticsInvestor & Chairperson2021 β€” 2025Israel
  7. Lin HealthBoard Observer2021 β€” 2022Colorado, United States
  8. ITTN - Israel Technology Transfer OrganizationCo Chairman2018 β€” 2019
  9. Yissum Research Development Company of the Hebrew UniversityPresident & CEO2017 β€” 2019Jerusalem Area, Israel
  10. The College of Management Academic StudiesHead of Bio-MBA Program2010 β€” 2018Rishon Le-Tziyon, Israel
  11. AlcobraChairman Of The Board2017Tel Aviv Area, Israel
  12. AlcobraPresident & CEO2010 β€” 2017Tel Aviv, Israel and Plymouth Meeting, PA (USA)
  13. Bioblast Ltd.Director2012 β€” 2014Tel Aviv, Israel
  14. NanoCyte, Inc.President & CEO2007 β€” 2010
  15. Gamida Cell Ltd.VP Business Development2003 β€” 2007
  16. American Cancer SocietyPostdoctoral Fellow2000 β€” 2003

Skills & more

InvestmentsBusiness UnderstandingNew Venture FormationBoard of DirectorsDue Diligence27Competitive Intelligence15Regulatory Strategy11Start-ups55Biotechnology64Product Development32Venture Capital20Technology Transfer13
+12 moreProtein ChemistryLifesciencesLife SciencesBusiness DevelopmentCommercializationBiopharmaceuticalsEntrepreneurshipBusiness StrategyTeam ManagementStrategyManagementPharmaceutical Development

From Yaron's professional profile.

Colleagues at aMoon

Frequently asked questions

Who is Yaron Daniely?
Yaron Daniely is a General Partner at aMoon, where he co-leads Velocity, an early-stage fund focused on cutting-edge technologies aimed at accelerating cures. Before aMoon, he was President and CEO of Yissum, Hebrew University's technology transfer company, and Co-Chairperson of the Israel Technology Transfer Network, following 14 years as a senior executive (10 as CEO) at private and NASDAQ-traded biopharma and biotech companies. He holds a PhD from the Sackler Institute of Graduate Biomedical Sciences at NYU School of Medicine and an MBA from the Technion.
Where does Yaron Daniely work?
Yaron Daniely is General Partner at aMoon.
What does Yaron Daniely invest in?
Yaron Daniely invests in Biotech, Digital Health, Healthtech.
Where did Yaron Daniely go to school?
Yaron Daniely studied at New York University (Ph.D., Biochemistry); Technion - Israel Institute of Technology (MBA, Entrepreneurship/Entrepreneurial Studies); NIH (Post-Doc, Skin Stem Cells).

Same school

Shared employers